These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10779132

  • 21. Low-dose glycopyrrolate for clozapine-associated sialorrhea.
    Praharaj SK, Munoli RN, Sharma PS.
    J Clin Psychopharmacol; 2014 Jun; 34(3):392. PubMed ID: 24717248
    [No Abstract] [Full Text] [Related]

  • 22. Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions.
    Zeller RS, Davidson J, Lee HM, Cavanaugh PF.
    Ther Clin Risk Manag; 2012 Jun; 8():25-32. PubMed ID: 22298951
    [Abstract] [Full Text] [Related]

  • 23. [Glycopyrrolate, an alternative to deptropine citratie when treating sialorrhea].
    Cosaert K, Willems L, Spriet I.
    J Pharm Belg; 2010 Mar; (1):22-3. PubMed ID: 20429392
    [No Abstract] [Full Text] [Related]

  • 24. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR, Todhunter E, Pennington L, Stocken D, Cadwgan J, O'Hare AE, Tuffrey C, Williams J, Cole M, Colver AF.
    Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
    [Abstract] [Full Text] [Related]

  • 25. Glycopyrrolate for clozapine-induced sialorrhea.
    Duggal HS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1546-7. PubMed ID: 17614181
    [No Abstract] [Full Text] [Related]

  • 26. Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports.
    Agbi KE, Carvalho M, Vieira-Banov F.
    Int J Pharm Compd; 2021 Oct 01; 25(6):464-467. PubMed ID: 34807840
    [Abstract] [Full Text] [Related]

  • 27. In brief: Glycopyrrolate oral solution for sialorrhea.
    Med Lett Drugs Ther; 2011 Jan 10; 53(1355):4. PubMed ID: 21212745
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.
    Sridharan K, Sivaramakrishnan G.
    J Clin Neurosci; 2018 May 10; 51():12-17. PubMed ID: 29475576
    [Abstract] [Full Text] [Related]

  • 29. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
    Man WH, Colen-de Koning JC, Schulte PF, Cahn W, van Haelst IM, Doodeman HJ, Egberts TC, Heerdink ER, Wilting I.
    J Clin Psychopharmacol; 2017 Apr 10; 37(2):155-161. PubMed ID: 28129312
    [Abstract] [Full Text] [Related]

  • 30. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ.
    Dev Med Child Neurol; 2006 Feb 10; 48(2):103-7. PubMed ID: 16417664
    [Abstract] [Full Text] [Related]

  • 31. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 10; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 32. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
    Arbouw ME, Movig KL, Koopmann M, Poels PJ, Guchelaar HJ, Egberts TC, Neef C, van Vugt JP.
    Neurology; 2010 Apr 13; 74(15):1203-7. PubMed ID: 20385892
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials.
    Kerwin E, Donohue JF, Goodin T, Tosiello R, Wheeler A, Ferguson GT.
    Respir Med; 2017 Nov 13; 132():238-250. PubMed ID: 28838685
    [Abstract] [Full Text] [Related]

  • 34. Randomized Phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions.
    Zeller RS, Lee HM, Cavanaugh PF, Davidson J.
    Ther Clin Risk Manag; 2012 Nov 13; 8():15-23. PubMed ID: 22298950
    [Abstract] [Full Text] [Related]

  • 35. Modafinil for drooling in cerebral palsy.
    Hurst D, Cedrone N.
    J Child Neurol; 2006 Feb 13; 21(2):112-4. PubMed ID: 16566873
    [Abstract] [Full Text] [Related]

  • 36. The when, why, and how of using glycopyrronium to diminish drooling in children with neurodevelopmental disabilities: Implications for clinical practice.
    Orriëns LB, van der Burg JJW, van den Hoogen FJA, Willemsen MAAP, van Hulst K, Erasmus CE.
    Eur J Paediatr Neurol; 2024 Jul 13; 51():24-31. PubMed ID: 38776696
    [Abstract] [Full Text] [Related]

  • 37. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling.
    van der Burg JJ, Jongerius PH, van Limbeek J, van Hulst K, Rotteveel JJ.
    Eur J Pediatr; 2006 Jan 13; 165(1):37-41. PubMed ID: 16172877
    [Abstract] [Full Text] [Related]

  • 38. Sialorrhea - therapeutic drug options.
    Tscheng DZ.
    Ann Pharmacother; 2002 Nov 13; 36(11):1785-90. PubMed ID: 12398577
    [Abstract] [Full Text] [Related]

  • 39. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy.
    Reddihough D, Johnson H, Staples M, Hudson I, Exarchos H.
    Dev Med Child Neurol; 1990 Nov 13; 32(11):985-9. PubMed ID: 2269408
    [Abstract] [Full Text] [Related]

  • 40. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
    Robb AS, Lee RH, Cooper EB, Siedel JV, Nusrat N.
    J Child Adolesc Psychopharmacol; 2008 Feb 13; 18(1):99-107. PubMed ID: 18294092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.